Newsroom
Sorted by: Latest
-
Vertex to Acquire Crinetics Pharmaceuticals
BOSTON & SAN DIEGO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately...
-
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 96,450 shares of the Company’s common stock to six new employees (the “Inducement Grants”) on July 6, 2026 (the “Grant Date”). The Inducemen...
-
Caesars Entertainment, Inc. to Report 2026 Second Quarter Results on July 28, 2026
LAS VEGAS & RENO, Nev.--(BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”, “the Company”) will release its financial results for the second quarter after the market closes on Tuesday, July 28, 2026. Considering the Company’s pending merger agreement with Fertitta Entertainment announced on May 28, 2026, Caesars will not host an earnings call this quarter. Upon completion of the proposed merger agreement, Caesars’ common stock will no longer be listed on NASDAQ, and the Compan...
-
Seacoast Banking Corporation of Florida to Announce Second Quarter Earnings Results July 28, 2026
STUART, Fla.--(BUSINESS WIRE)--Seacoast Banking Corporation of Florida (NASDAQ: SBCF), a bank holding company whose operating entity is Seacoast Bank, today announced it will release second quarter 2026 results on July 28th, after the market closes. Upon release, investors may access a copy of Seacoast’s earnings results at the company’s website www.SeacoastBanking.com on the home page by selecting “Press Releases” under the heading “News/Events.” Seacoast will host a conference call July 29th...
-
Turn Therapeutics to Host Webcast Presenting Comprehensive Interim Analysis and Optimized Stage 2 Design for GX-03 in Atopic Dermatitis
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast on Tuesday, July 7, 2026, to present key findings from the comprehensive interim analysis of its ongoing adaptive Phase 2 trial of GX-03 in atopic dermatitis. The Company will issue a press release tomorrow morning detailing these findings together with the...
-
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to eight newly hired non-executive employees consisting of options to purchase an aggregate of 169,740 common shares of the Company (the "Options") with effective grant dates of July 6, 2026...
-
Empery Digital Terminates Limited-Duration Shareholder Rights Plan
AUSTIN, Texas--(BUSINESS WIRE)--Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) announced today that the Company’s Board of Directors (the “Board”) approved an amendment to the Company’s stockholder rights plan (the “rights plan”) to accelerate the expiration date to the close of business on July 6, 2026. The rights plan was scheduled to expire on February 2, 2027. In deciding to terminate the rights plan, the Board determined that maintaining the rights plan is no longer...
-
L3Harris Sets Date for Second Quarter 2026 Earnings Release
MELBOURNE, Fla.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) will release its second quarter 2026 financial results after the market closes on Wednesday, July 29, 2026.The company will then host an earnings call on Wednesday, July 29, 2026, at 5 p.m. ET. Participants are encouraged to listen via webcast at L3Harris.com. A replay of the call will also be available on L3Harris.com following the event.About L3Harris TechnologiesL3Harris is the Trusted Disruptor in defense tech. With customer...
-
LogProstyle Announces Date for Release of Full Year 2026 Financial Results
TOKYO--(BUSINESS WIRE)--LogProstyle Inc. (NYSE American: LGPS) (the “Company” or “LogProstyle”), headquartered in Minato-ku, Tokyo, Japan, announced today that it will release its financial results for the full fiscal year ended March 31, 2026 (“FY2026”) at 8:00 a.m. Eastern Time on July 13, 2026. In connection with the results, the Company will make available a pre-recorded presentation reviewing its FY2026 financial and operational performance. The presentation will be accessible on the Compa...
-
UpsideOnly, la plataforma de negociación libre de pérdidas, supera los 100 000 usuarios a pocas semanas de su lanzamiento
SAN FRANCISCO--(BUSINESS WIRE)--Perpetuals.com Ltd (Nasdaq: PDC), anunció hoy que UpsideOnly, su plataforma de negociación libre de riesgo y predicción de mercados, ha registrado un fuerte aumento en el número de nuevos usuarios, superando el importante hito de 100 000 operadores apenas unas semanas después de su lanzamiento, el pasado 19 de mayo. UpsideOnly permite a los usuarios predecir la dirección de los mercados globales de acciones, materias primas, divisas y criptomonedas sin realizar o...